5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) — a research tool for investigating NAD+ metabolism, methylation balance, and adipocyte differentiation pathways.

AOD-9604 (Anti-Obesity Drug 9604) is the synthetic C-terminal 16-residue fragment of human growth hormone — a research tool that retains lipolytic activity without IGF-1 axis activation.

Retatrutide is the first-in-class triple receptor agonist of GIP, GLP-1, and glucagon receptors — the most advanced incretin research compound available in 2026. A complete research-context overview.

A side-by-side research comparison of three incretin-class peptides: Semaglutide (mono-agonist), Tirzepatide (dual agonist), and Retatrutide (triple agonist). Molecular profiles, mechanisms, and comparative research applications.

A complete research-context overview of Tirzepatide — the synthetic 39-amino-acid dual GIP/GLP-1 receptor agonist that has redefined incretin research. Mechanism, comparison with Semaglutide and Retatrutide, and current research applications.